Our experiments corroborated these findings, showing reductions in Aβ deposition, oxidative stress markers (MDA and 4-HNE), and neuroinflammatory markers (GFAP and Iba-1) in AD mouse brain tissue treated with acorn polyphenols, highlighting their potential to delay AD progression. This evidence concerns the gene GFAP and Alzheimer disease.